Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. Aug 15, 2019
Intellipharmaceutics International Inc. Announces Update on its Oxycodone ER New Drug Application Jul 24, 2019
Intellipharmaceutics International Inc. Announces $10,000,000 Equity Financing Commitment Jul 8, 2019
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing with Drs. Isa and Amina Odidi May 7, 2019
